PAR 8.00% 23.0¢ paradigm biopharmaceuticals limited..

PAR Investor Meeting - Questions from HC, page-11

  1. 9,808 Posts.
    lightbulb Created with Sketch. 1243
    *******PEER REVIEW OF 2B TRIAL DATA******** Due June 2021
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.